FY2022 NDAA : COVID-19 vaccination-related provisions /
| Main Author: | Mendez, Bryce H. P. (Author) |
|---|---|
| Format: | Government Document Database |
| Language: | English |
| Published: |
[Washington, D.C.] :
Congressional Research Service,
2022-
|
| Edition: | [Library of Congress public edition]. |
| Series: | Insight (Library of Congress. Congressional Research Service) ;
IN11842. |
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo215377 |
Similar Items
FY2022 NDAA : procurement authorizations /
by: McGarry, Brendan W.
Published: (2022)
by: McGarry, Brendan W.
Published: (2022)
FY2022 NDAA : military construction authorizations /
by: McGarry, Brendan W.
Published: (2022)
by: McGarry, Brendan W.
Published: (2022)
FY2022 NDAA : active component end-strength /
by: Kapp, Lawrence
Published: (2022)
by: Kapp, Lawrence
Published: (2022)
FY2022 NDAA : research, development, test and evaluation authorizations /
by: McGarry, Brendan W.
Published: (2022)
by: McGarry, Brendan W.
Published: (2022)
FY2022 NDAA : Overseas Contingency Operations /
by: McGarry, Brendan W.
Published: (2022)
by: McGarry, Brendan W.
Published: (2022)
FY2022 NDAA : strategic context /
by: McGarry, Brendan W., et al.
Published: (2021)
by: McGarry, Brendan W., et al.
Published: (2021)
FY2022 NDAA : summary of discretionary authorizations /
by: McGarry, Brendan W.
Published: (2022)
by: McGarry, Brendan W.
Published: (2022)
FY2022 NDAA : Preservation of the Force and Family program /
by: Kamarck, Kristy N., et al.
Published: (2021)
by: Kamarck, Kristy N., et al.
Published: (2021)
FY2022 NDAA : Selective Service and draft registration /
by: Kamarck, Kristy N.
Published: (2021)
by: Kamarck, Kristy N.
Published: (2021)
FY2022 NDAA : status of legislative activity /
by: McGarry, Brendan W., et al.
Published: (2021)
by: McGarry, Brendan W., et al.
Published: (2021)
FY2022 NDAA : budgetary context /
by: McGarry, Brendan W., et al.
Published: (2021)
by: McGarry, Brendan W., et al.
Published: (2021)
FY2022 NDAA : mental health care /
by: Mendez, Bryce H. P.
Published: (2021)
by: Mendez, Bryce H. P.
Published: (2021)
FY2022 NDAA : extremism in the military /
by: Kamarck, Kristy N.
Published: (2021)
by: Kamarck, Kristy N.
Published: (2021)
FY2022 NDAA : parental leave benefits /
by: Kamarck, Kristy N., et al.
Published: (2021)
by: Kamarck, Kristy N., et al.
Published: (2021)
FY2022 NDAA : President's budget request /
by: McGarry, Brendan W.
Published: (2021)
by: McGarry, Brendan W.
Published: (2021)
Hearing on National Defense Authorization Act for Fiscal Year 2022 and oversight of previously authorized programs, before the Committee on Armed Services, House of Representatives, One Hundred Seventheenth Congress, first session : full committee hearing on nongovernmental views on the fiscal year 2022 Department of Defense budget, hearing held July 20, 2021.
Published: (2023)
Published: (2023)
Autoimmunity, COVID-19, post-COVID-19 syndrome and COVID-19 vaccination /
Published: (2022)
Published: (2022)
PPBE Reform Commission final report recommendations : issues for Congress /
by: McGarry, Brendan W.
Published: (2024)
by: McGarry, Brendan W.
Published: (2024)
Overview of R0 and vaccine coverage required for COVID-19 herd immunity.
Published: (2020)
Published: (2020)
Alexandria Public Health Department : COVID vaccine initiative.
Published: (2022)
Published: (2022)
Indonesian and Philippine media on China and Covid-19 /
by: Hung, Jason
Published: (2024)
by: Hung, Jason
Published: (2024)
FY2024 NDAA funding authorizations and legislative activity : in brief /
by: McGarry, Brendan W.
Published: (2024)
by: McGarry, Brendan W.
Published: (2024)
Compensation programs for potential COVID-19 vaccine injuries /
by: Hickey, Kevin J., et al.
Published: (2021)
by: Hickey, Kevin J., et al.
Published: (2021)
COVID-19 vaccine development.
Published: (2020)
Published: (2020)
COVID-19 vaccine trials at St. Louis institutions now include Johnson & Johnson's Janssen vaccine.
Published: (2020)
Published: (2020)
Compensation for COVID-19 vaccine injuries /
by: Hickey, Kevin J., et al.
Published: (2021)
by: Hickey, Kevin J., et al.
Published: (2021)
Vaccine safety in the United States : overview and considerations for COVID-19 vaccines /
by: Sekar, Kavya, et al.
Published: (2020)
by: Sekar, Kavya, et al.
Published: (2020)
COVID-19 variants : vaccines, diagnostics, and therapeutics /
by: Sarata, Amanda K., et al.
Published: (2021)
by: Sarata, Amanda K., et al.
Published: (2021)
Economist video. when will a vaccine be ready? /
Published: (2020)
Published: (2020)
State and federal authority to mandate COVID-19 vaccination /
by: Shen, Wen W.
Published: (2021)
by: Shen, Wen W.
Published: (2021)
Hurry up with the vaccines to boost economy says OECD.
Published: (2021)
Published: (2021)
Domestic funding for COVID-19 vaccines : an overview /
by: Sekar, Kavya
Published: (2021)
by: Sekar, Kavya
Published: (2021)
The COVID-19 vaccine void : when should patents be waived? /
by: Rae, Madeline
Published: (2021)
by: Rae, Madeline
Published: (2021)
Tracking COVID-19 vaccines : U.S. data systems and related issues /
by: Sekar, Kavya
Published: (2021)
by: Sekar, Kavya
Published: (2021)
Answering your questions about the new COVID-19 vaccines.
Published: (2021)
Published: (2021)
Answering your questions about the safety and effectiveness of COVID-19 vaccines.
Published: (2021)
Published: (2021)
How Pfizer and BioNTech made history with their vaccine.
Published: (2021)
Published: (2021)
COVID-19 and vaccine nationalism : managing the politics of global pandemics /
by: Otenyo, Eric Edwin
Published: (2023)
by: Otenyo, Eric Edwin
Published: (2023)
COVID-19 antibodies and vaccines may be less effective against some fast-spreading variants.
Published: (2020)
Published: (2020)
Nasal spray vaccine against COVID-19 prevents infection in mice and moving closer to clinical trials.
Published: (2020)
Published: (2020)